Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Therapeutic drug monitoring in highly active antiretroviral therapy.

Expert opinion on drug safety - 1 Sept 2010

Liu Xia, Ma Qing, Zhang Fujie

Abstract excerpt

IMPORTANCE OF THE FIELD: Despite the efficacy of combination antiretroviral therapy (ART), a large proportion of patients living with HIV/AIDS on ART does not achieve or maintain adequate virological suppression. Therapeutic drug monitoring (TDM) has been utilised to improve treatment outcomes of ART. AREAS COVERED IN THE REVIEW: The potential incorporation of TDM into the clinical HIV management is supported by...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biotransformation
Share to Developing Countries
Share to Drug Monitoring

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drugs, Chinese Herbal

Share to Liver Diseases

Share to Multicenter Studies as Topic

Share to Pregnancy Complications, Infectious

Share to Substance Abuse, Intravenous

Source

Identifiers

PMID: 20350281
DOI: 10.1517/14740331003767395

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Therapeutic drug monitoring in highly active antiretroviral therapy.PMID 20350281Read ↗

Therapeutic drug monitoring of antiretroviral therapy.Semantic proximity Read ↗

Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.Semantic proximity Read ↗

Approaches for understanding and predicting drug interactions in human immunodeficiency virus-infected patientsSemantic proximity Read ↗

The pharmacokinetics, pharmacodynamics and pharmacogenetics of Dolutegravir and Cobicistat in the treatment of HIVSemantic proximity Read ↗

Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?Semantic proximity Read ↗

Investigation of molecular mechanisms regulating drug-drug interactions in antiretroviral therapySemantic proximity Read ↗

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.Semantic proximity Read ↗

Recent advances in antiretroviral therapy and HIV infection monitoring.Semantic proximity Read ↗

Therapeutic drug monitoring of the HIV protease inhibitor atazanavir in clinical practice.Semantic proximity Read ↗

Antiretroviral therapy 2006: pharmacology, applications, and special situations.Semantic proximity Read ↗

Pharmacokinetic-pharmacodynamic relationship of NRTIs and its connection to viral escape: an example based on zidovudine.Semantic proximity Read ↗

A High-Performance Liquid Chromatography-Mass Spectrometry method for simultaneous determination of dolutegravir, nevirapine, efavirenz, rifampicin and rifapentine concentrations in human plasmaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.